Richar CR Tablet contains ferrous ascorbate and folic acid which is a nutritional supplement for a healthy functional body. It helps the body to make red blood and nerve cells. During pregnancy the body?s demands for iron and folic acid increase. Iron is important for the health of the mother and developing baby. Not enough iron may lead to anaemia in either the mother or baby. It is therefore important that the body gets enough iron for both the mother and the developing baby.
Ferrous ascorbate is an iron supplement used to treat or prevent low blood levels of iron (such as those caused by anemia or during pregnancy). Iron and folic acid is important for the health of the mother and developing baby.
Folic acid is required to regulate the growth of cells including red blood cells and protein synthesis. It is used to treat low folate levels.
KEY COMPOSITION OF RICHAR CR TABLET:
THERAPEUTIC USES OF RICHAR CR TABLET:
Helps the body to make red blood and nerve cells
Used for the treatment of iron deficiency anemia
Improves the immunity of the body
Used to treat low folate levels
Used as pre-natal supplement
SIDE EFFECTS OF RICHAR CR TABLET:
Eat more high-fibre foods such as fresh fruit, vegetables and cereals, and drink plenty of water. Try to exercise more regularly, for example, by going for a daily walk or run.
DARK OR BLACK STOOLS:
This is common when taking iron and is nothing to worry about. Talk to a doctor if your stool is black and sticky looking, has red streaks in it, or if you also feel unwell in any other way.
Always take the Richar CR Tablet as instructed by the physician.
It is considered safe for use by pregnant women. It is advised to consult your doctor before taking.
Check with your healthcare provider if you experience any unusual side effects.
Tell your doctor about all the medicines you use, including prescription and non-prescription medicines and herbal supplements.
Keep this medicine out of reach of children.
Store in a dry place below 30°C.
Protect from light and moisture.
There are no reviews yet.